Alexandria prices one billion dollars in subordinated notes
The notes bear a 7.250% interest rate through 2032, with proceeds allocated for working capital and debt reduction.
See the latest news and media coverage for Alexandria. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life science–focused real estate investment trust
are.comLast updated
In short: Alexandria navigated a tough life sciences market by reporting mixed financial results, pricing $1 billion in notes, and selling assets.
The notes bear a 7.250% interest rate through 2032, with proceeds allocated for working capital and debt reduction.
Net loss was $73.7 million, and FFO as adjusted was $296.1 million. Occupancy of operating properties was 86.9%.
The hub at Campus Point Megacampus strengthens the ecosystem, achieving 95.4% occupancy and enabling innovation for life science entities.
The report highlights the company's strategic integration of mission, innovation, and long-term value creation.
Alexandria Real Estate Equities has been steadily selling real estate, even in Kendall Square, in recent years to reflect the steep decline in demand for...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or...
Alexandria Real Estate Equities is mispriced as a distressed office REIT, offering a 'Strong Buy' opportunity. ARE's specialized life sciences campuses in top biotech hubs...
The life sciences developer is still feuding with the city over a third building planned for the Alexandria Center for Life ...
Track Alexandria and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Alexandria and other trending companies.